Drug:
Reaction: ILLNESS
20250101 - 20251231
No. 401 - 500
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 401 | 25098142 |
US |
1 | |
Illness, |
||||
PANCRELIPASE, |
||||
| 402 | 25098191 |
US |
2 | |
Illness, |
||||
ADALIMUMAB, |
||||
| 403 | 25098370 |
US |
2 | |
Mast cell activation syndrome, Loss of consciousness, Syncope, Illness, Autonomic nervous system imbalance, Brain fog, Bradycardia, Tachycardia, Therapy interrupted, Off label use, |
||||
IVABRADINE, IVABRADINE, IVABRADINE, IVABRADINE, PROPRANOLOL HYDROCHLORIDE, ATENOLOL, FAMOTIDINE, |
||||
| 404 | 25098421 |
US |
2 | |
Illness, Viral infection, |
||||
ADALIMUMAB, |
||||
| 405 | 25098437 |
US |
2 | |
Surgery, Illness, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 406 | 25098578 |
GB |
65 | 1 |
Illness, Nasal congestion, Malaise, |
||||
TAMSULOSIN HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, |
||||
| 407 | 25098803 |
CA |
68 | 2 |
Rectal haemorrhage, Illness, Therapeutic reaction time decreased, Diarrhoea, Anal incontinence, Oral herpes, Frequent bowel movements, Discomfort, Asthenia, Fatigue, |
||||
VEDOLIZUMAB, VEDOLIZUMAB, MESALAMINE, PREDNISONE, |
||||
| 408 | 25098885 |
DO |
69 | 1 |
Hospitalisation, Illness, Lymphadenopathy, |
||||
IBRUTINIB, |
||||
| 409 | 25098933 |
US |
1 | |
Illness, Nasopharyngitis, Off label use, |
||||
LENALIDOMIDE, |
||||
| 410 | 25099204 |
US |
69 | |
Malignant neoplasm progression, Illness, |
||||
CETUXIMAB, |
||||
| 411 | 25099465 |
US |
2 | |
Illness, |
||||
ALEMTUZUMAB, |
||||
| 412 | 25099617 |
US |
2 | |
Illness, Condition aggravated, Surgery, |
||||
DUPILUMAB, SUCRALFATE, CYANOCOBALAMIN, FLUTICASONE PROPIONATE, ALBUTEROL SULFATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, CETIRIZINE HYDROCHLORIDE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, ZOLPIDEM TARTRATE, FENOFIBRATE, ALPRAZOLAM, |
||||
| 413 | 25099644 |
US |
63 | 1 |
Illness, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 414 | 25099712 |
US |
2 | |
Illness, |
||||
ADALIMUMAB, |
||||
| 415 | 25099882 |
BR |
52 | 2 |
Metastases to bone, Spinal deformity, Decreased immune responsiveness, Lip dry, Dry throat, Sluggishness, Throat clearing, Vulvovaginal dryness, Visual impairment, Concomitant disease aggravated, Atrophy, Gait inability, Illness, Intervertebral disc protrusion, Dry skin, Platelet count decreased, Nausea, Cough, Nausea, Asthenia, Eating disorder, Weight increased, Muscle spasms, Hypoaesthesia, Limb discomfort, Insomnia, Adverse drug reaction, Anxiety, Decreased appetite, Weight decreased, Decreased immune responsiveness, Fear, Pain in extremity, Bone pain, Vomiting, |
||||
RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 416 | 25099998 |
CA |
60 | |
Asthma, Bronchitis, Dyspnoea, Loss of personal independence in daily activities, Malaise, Pneumonia, Sleep disorder due to a general medical condition, Therapeutic product effect incomplete, Illness, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, MEPOLIZUMAB, ALBUTEROL SULFATE, MONTELUKAST SODIUM, TIOTROPIUM BROMIDE, |
||||
| 417 | 25100047 |
US |
65 | 2 |
Suicidal ideation, Illness, Dizziness, |
||||
TOFACITINIB, |
||||
| 418 | 25100144 |
US |
2 | |
Myasthenia gravis crisis, Glaucoma, Illness, Migraine, Nasopharyngitis, |
||||
ROZANOLIXIZUMAB, PREDNISONE, |
||||
| 419 | 25100301 |
US |
58 | 1 |
Illness, Intentional product use issue, Off label use, |
||||
LEUPROLIDE ACETATE, LEUPROLIDE ACETATE, |
||||
| 420 | 25100326 |
IN |
42 | 1 |
Illness, |
||||
AXITINIB, |
||||
| 421 | 25100642 |
US |
2 | |
Large intestine infection, Haemoglobin decreased, Illness, |
||||
MITAPIVAT, |
||||
| 422 | 25100676 |
US |
1 | |
Illness, |
||||
TOLVAPTAN, TOLVAPTAN, ALLOPURINOL, ALLOPURINOL, ALPRAZOLAM, ALPRAZOLAM, BUPROPION HYDROCHLORIDE, BUPROPION, CARVEDILOL, COLCHICINE, LISINOPRIL, METHYLPREDNISOLONE, PANTOPRAZOLE, POTASSIUM CITRATE, POTASSIUM CITRATE, |
||||
| 423 | 25100720 |
US |
||
Infusion site pain, Infusion site reaction, Illness, Drug tolerance decreased, Device issue, Device occlusion, Device alarm issue, Patient dissatisfaction with device, Device wireless communication issue, Device occlusion, Device issue, Device issue, Device alarm issue, Device wireless communication issue, Device use issue, Device adhesion issue, Device dislocation, |
||||
TREPROSTINIL, |
||||
| 424 | 25100840 |
US |
||
Illness, |
||||
RAVULIZUMAB, ECULIZUMAB, |
||||
| 425 | 25100866 |
US |
2 | |
Diabetes mellitus, Glucose tolerance impaired, Amnesia, Condition aggravated, Eye infection, Illness, Nervousness, Injection site pain, Hypoaesthesia, Muscular weakness, Pain in extremity, Stress, Dizziness, Nausea, Nausea, Asthenia, |
||||
FINGOLIMOD HCL, FINGOLIMOD HCL, OFATUMUMAB, |
||||
| 426 | 25100894 |
US |
2 | |
Illness, Post-acute COVID-19 syndrome, |
||||
SECUKINUMAB, |
||||
| 427 | 25100962 |
US |
||
Dizziness, Headache, Injection site pain, Illness, Fatigue, Chest pain, Dyspnoea, Nasal congestion, Pain, Influenza like illness, Oropharyngeal pain, |
||||
NEMOLIZUMAB-ILTO, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, PROGESTERONE, NALTREXONE, |
||||
| 428 | 25101290 |
US |
60 | 2 |
Death, Pain in jaw, Gastrointestinal disorder, Upper respiratory tract infection, Poor quality sleep, Dry mouth, Parotid gland enlargement, Bronchitis, Emphysema, COVID-19, Skin disorder, Alopecia, Joint dislocation, Insurance issue, Skin lesion, Illness, Amnesia, Oropharyngeal pain, Lymphadenopathy, Malaise, Fatigue, Migraine, Headache, Infusion site pain, Nausea, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
| 429 | 25101416 |
US |
54 | 2 |
Illness, Nasopharyngitis, Off label use, |
||||
LENALIDOMIDE, |
||||
| 430 | 25101453 |
US |
2 | |
Inflammatory marker increased, C-reactive protein increased, Illness, Feeling abnormal, |
||||
CANAKINUMAB, |
||||
| 431 | 25101485 |
ZA |
85 | |
Biliary tract dilation procedure, Vascular graft, Illness, Infection, |
||||
DAPAGLIFLOZIN, TELMISARTAN, CELECOXIB, ROSUVASTATIN, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, ESTRADIOL, BISOPROLOL FUMARATE, |
||||
| 432 | 25101520 |
US |
64 | 2 |
Illness, |
||||
ABATACEPT, |
||||
| 433 | 25101524 |
US |
79 | 2 |
Illness, Acute lymphocytic leukaemia recurrent, Respiratory failure, Cytopenia, Arteriosclerosis coronary artery, Pneumonia, Pneumothorax, Pleural effusion, Infection, |
||||
PREDNISONE, DASATINIB, DASATINIB, DASATINIB, NILOTINIB, BOSUTINIB, BOSUTINIB, METHOTREXATE, METHOTREXATE SODIUM, MERCAPTOPURINE, |
||||
| 434 | 25101600 |
US |
72 | 2 |
Cholecystectomy, Nerve compression, Illness, Hypotension, Hypertension, Muscle spasms, Dizziness, Weight decreased, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN C, FERROUS SULFATE, PSYLLIUM HUSK, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, ARMODAFINIL, |
||||
| 435 | 25101691 |
US |
62 | 2 |
Illness, |
||||
SECUKINUMAB, |
||||
| 436 | 25101752 |
US |
||
Illness, Product use issue, Off label use, |
||||
PANTOPRAZOLE, |
||||
| 437 | 25101763 |
US |
||
Illness, Lung disorder, Fatigue, |
||||
CONJUGATED ESTROGENS AND MEDROXYPROGESTERONE ACETATE, |
||||
| 438 | 25101855 |
US |
34 | 1 |
Headache, Asthenia, Fatigue, Illness, Product dose omission issue, |
||||
DOLUTEGRAVIR SODIUM AND RILPIVIRINE HYDROCHLORIDE, |
||||
| 439 | 25101921 |
US |
1 | |
Illness, Diabetes mellitus, Drug hypersensitivity, Angiopathy, Crohn^s disease, Therapeutic product effect decreased, |
||||
ADALIMUMAB, |
||||
| 440 | 25101933 |
US |
2 | |
Condition aggravated, Illness, Influenza like illness, Migraine, Nausea, Fatigue, Inadequate analgesia, Product substitution issue, |
||||
| 441 | 25101959 |
US |
2 | |
Headache, Anxiety, Drug ineffective, Abdominal pain upper, Brain fog, Fatigue, Malaise, Depression, Disturbance in attention, Apathy, Illness, Insurance issue, |
||||
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, ERGOCALCIFEROL, METHYLPHENIDATE HYDROCHLORIDE, BUPROPION HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, LISDEXAMFETAMINE DIMESYLATE, DEXTROAMPHETAMINE, |
||||
| 442 | 25102112 |
US |
52 | 2 |
Hair disorder, Hypotension, Illness, |
||||
DEUCRAVACITINIB, SPIRONOLACTONE, |
||||
| 443 | 25102201 |
US |
77 | 2 |
Drug intolerance, Illness, Gait inability, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, TREPROSTINIL, TREPROSTINIL, FLUTICASONE PROPIONATE, FAMOTIDINE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TADALAFIL, MAGNESIUM, ERGOCALCIFEROL, PROPRANOLOL HYDROCHLORIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, MACITENTAN, CORTISONE ACETATE, BUMETANIDE, CALCIUM CARBONATE, IRON, ZOLEDRONIC ACID, DIGOXIN, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CETIRIZINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, |
||||
| 444 | 25102208 |
US |
1 | |
Illness, Vomiting, |
||||
TIRZEPATIDE, |
||||
| 445 | 25102232 |
GB |
2 | |
Illness, |
||||
TERIPARATIDE, |
||||
| 446 | 25102288 |
CA |
72 | 1 |
Illness, |
||||
IBRUTINIB, IBRUTINIB, |
||||
| 447 | 25102396 |
US |
54 | 1 |
Surgery, Illness, |
||||
RISANKIZUMAB-RZAA, |
||||
| 448 | 25104366 |
51 | 2 | |
Illness, Therapy interrupted, |
||||
ETANERCEPT, |
||||
| 449 | 25104747 |
26 | 2 | |
Illness, |
||||
IXEKIZUMAB, |
||||
| 450 | 25104750 |
66 | 1 | |
Illness, |
||||
UPADACITINIB, |
||||
| 451 | 25092104 |
US |
68 | 1 |
Device difficult to use, Drug dose omission by device, Accidental exposure to product, Nasopharyngitis, Illness, |
||||
EVOLOCUMAB, |
||||
| 452 | 25092140 |
US |
2 | |
Pyrexia, Condition aggravated, Illness, Product use issue, Off label use, |
||||
CANAKINUMAB, CANAKINUMAB, CANAKINUMAB, |
||||
| 453 | 25092141 |
US |
34 | 2 |
Pre-eclampsia, Live birth, Illness, Maternal exposure during pregnancy, Puerperal infection, |
||||
RISANKIZUMAB-RZAA, |
||||
| 454 | 25092156 |
US |
5 | 2 |
Illness, Anxiety, Depression, |
||||
ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, ESKETAMINE HYDROCHLORIDE, |
||||
| 455 | 25092190 |
US |
53 | 2 |
Eye pruritus, Nasal congestion, Headache, Illness, |
||||
MEPOLIZUMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, PANTOPRAZOLE, ALBUTEROL SULFATE, ALBUTEROL, BUPROPION HYDROCHLORIDE, CLONAZEPAM, FUROSEMIDE, FLUTICASONE PROPIONATE, GABAPENTIN, ZOLPIDEM TARTRATE, ZOLEDRONIC ACID, ERENUMAB-AOOE, |
||||
| 456 | 25092329 |
CA |
2 | |
Arthralgia, Crying, Depressed mood, Device mechanical issue, Drug interaction, Fear, Gait inability, Illness, Monoplegia, Osteoarthritis, Pain, Post-traumatic stress disorder, Suicidal ideation, Victim of sexual abuse, Product dose omission issue, Treatment noncompliance, |
||||
CLONAZEPAM, ADALIMUMAB-FKJP, ADALIMUMAB-FKJP, |
||||
| 457 | 25092382 |
US |
61 | 2 |
Illness, |
||||
ABATACEPT, |
||||
| 458 | 25092612 |
US |
36 | 2 |
Visual impairment, Illness, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 459 | 25092679 |
US |
70 | 2 |
Illness, |
||||
LENALIDOMIDE, |
||||
| 460 | 25092738 |
US |
55 | 2 |
Colon cancer, Chest pain, Blood pressure increased, Illness, |
||||
FRUQUINTINIB, AMLODIPINE, HYDROXYZINE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, PANTOPRAZOLE, TIOTROPIUM BROMIDE, |
||||
| 461 | 25093132 |
US |
2 | |
Illness, Nausea, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 462 | 25093278 |
US |
2 | |
Product tampering, Illness, |
||||
TIRZEPATIDE, |
||||
| 463 | 25093501 |
US |
2 | |
Pharyngitis streptococcal, Diarrhoea, Illness, |
||||
OSELTAMIVIR PHOSPHATE, TROFINETIDE, |
||||
| 464 | 25093543 |
US |
32 | 2 |
Illness, |
||||
ABATACEPT, |
||||
| 465 | 25093546 |
US |
||
Hospitalisation, Illness, Product use issue, Product dose omission issue, |
||||
ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE, |
||||
| 466 | 25093589 |
CA |
||
Swelling face, Lip swelling, Eye swelling, SARS-CoV-2 test positive, Adverse event, Illness, Pyrexia, Cough, |
||||
ADALIMUMAB-FKJP, |
||||
| 467 | 25093705 |
NL |
32 | 1 |
Illness, Dyspnoea, Weight decreased, Pyrexia, |
||||
PALIVIZUMAB, PALIVIZUMAB, PALIVIZUMAB, |
||||
| 468 | 25094115 |
JP |
32 | 1 |
Illness, Device breakage, Drug dose omission by device, |
||||
AMIKACIN, |
||||
| 469 | 25094303 |
US |
1 | |
Illness, |
||||
PEGINTERFERON BETA-1A, PEGINTERFERON BETA-1A, |
||||
| 470 | 25094351 |
IE |
37 | 2 |
Oropharyngeal pain, Mouth ulceration, Dyspepsia, Glossodynia, Lip pain, Lip dry, Lip ulceration, Illness, |
||||
SECUKINUMAB, |
||||
| 471 | 25094431 |
CA |
39 | 2 |
Asthenia, Drug ineffective, Dysphonia, Fatigue, Hypersomnia, Ill-defined disorder, Illness, Malignant neoplasm progression, Metastases to lung, Metastases to the mediastinum, Nausea, Pleural effusion, |
||||
CAPECITABINE, CAPECITABINE, LETROZOLE, LETROZOLE, LETROZOLE, LETROZOLE, RIBOCICLIB, RIBOCICLIB, GOSERELIN, GOSERELIN, |
||||
| 472 | 25094468 |
US |
2 | |
Anaemia, Illness, |
||||
DUPILUMAB, IRON, HALOBETASOL PROPIONATE, ALBUTEROL SULFATE, HYDROCORTISONE, OIL, BIOTIN, HAIR, OLMESARTAN MEDOXOMIL, |
||||
| 473 | 25094499 |
US |
67 | 1 |
Cough, Illness, Off label use, Device breakage, Device delivery system issue, Device malfunction, |
||||
FLUTICASONE PROPIONATE AND SALMETEROL, |
||||
| 474 | 25094511 |
US |
||
Pleural effusion, Illness, Nasopharyngitis, Blood glucose increased, Abdominal discomfort, |
||||
ELACESTRANT, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 475 | 25094551 |
US |
25 | 2 |
Fatigue, Illness, |
||||
BELIMUMAB, |
||||
| 476 | 25094791 |
US |
67 | 2 |
Illness, Flushing, Erythema, Body temperature increased, Diarrhoea, Feeling hot, |
||||
AVAPRITINIB, |
||||
| 477 | 25094935 |
US |
61 | 2 |
Illness, |
||||
ABATACEPT, |
||||
| 478 | 25095113 |
GB |
54 | 1 |
Rheumatoid arthritis, Illness, Fatigue, General physical health deterioration, Mental disorder, Drug ineffective, |
||||
METHOTREXATE, METHOTREXATE SODIUM, CERTOLIZUMAB PEGOL, |
||||
| 479 | 25095331 |
US |
3 | 1 |
Pseudomonas infection, Sleep disorder, Behaviour disorder, Illness, |
||||
ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, ELEXACAFTOR, TEZACAFTOR, AND IVACAFTOR, |
||||
| 480 | 25095480 |
US |
9 | 2 |
Illness, Weight increased, |
||||
DUPILUMAB, |
||||
| 481 | 25095748 |
US |
||
Pneumonia, Illness, Dyspnoea, Arthropathy, Fall, Back pain, |
||||
BENRALIZUMAB, |
||||
| 482 | 25095904 |
BR |
1 | |
Seizure, Illness, Febrile convulsion, |
||||
PALIVIZUMAB, |
||||
| 483 | 25095944 |
US |
2 | |
Influenza like illness, Illness, |
||||
DUPILUMAB, MONTELUKAST, PREDNISONE, TIOTROPIUM BROMIDE, DULOXETINE HYDROCHLORIDE, DULOXETINE, |
||||
| 484 | 25096152 |
US |
8 | 1 |
Illness, |
||||
DUPILUMAB, MELATONIN, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, |
||||
| 485 | 25096393 |
US |
61 | 2 |
Weight decreased, Norovirus infection, Influenza, Illness, |
||||
TOFACITINIB, HYDROXYCHLOROQUINE SULFATE, |
||||
| 486 | 25096521 |
US |
1 | |
Illness, |
||||
TIRZEPATIDE, |
||||
| 487 | 25097101 |
ZA |
71 | |
Illness, |
||||
DAPAGLIFLOZIN, ENALAPRIL, PENTOXIFYLLINE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FUROSEMIDE, |
||||
| 488 | 25097132 |
US |
63 | 1 |
Illness, |
||||
APIXABAN, |
||||
| 489 | 25097213 |
CA |
||
Death, Illness, |
||||
| 490 | 25099313 |
64 | 1 | |
Illness, |
||||
SECUKINUMAB, |
||||
| 491 | 25099421 |
59 | 2 | |
Illness, |
||||
TOFACITINIB, |
||||
| 492 | 25099593 |
56 | 2 | |
Illness, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 493 | 25099661 |
64 | 1 | |
Illness, Therapy interrupted, |
||||
ADALIMUMAB, |
||||
| 494 | 25086732 |
GB |
||
Illness, |
||||
OSIMERTINIB, |
||||
| 495 | 25086836 |
US |
2 | |
Illness, |
||||
APIXABAN, |
||||
| 496 | 25086990 |
CA |
24 | 2 |
Band sensation, Maternal exposure during pregnancy, Blood creatinine increased, Body temperature increased, Creatinine urine decreased, Culture urine positive, Feeling hot, Immune thrombocytopenia, Lymphocyte count decreased, Monocyte count increased, Neutrophil count increased, Oropharyngeal pain, Pain in jaw, White blood cells urine positive, White blood cell count increased, Sensation of foreign body, Red blood cells urine positive, Skin burning sensation, Thyroid cyst, Thyroid disorder, Blood thyroid stimulating hormone abnormal, Urine abnormality, Blister, Anxiety, Chest pain, Constipation, Diarrhoea, Dizziness, Dyspnoea, Epistaxis, Feeling abnormal, Gastrooesophageal reflux disease, Heart rate increased, Hot flush, Insomnia, Malaise, Myalgia, Nasal congestion, Nausea, Panic attack, Tremor, Urticaria, Gastrooesophageal reflux disease, Tremor, Sensation of foreign body, Dyspnoea, Band sensation, Epistaxis, Thyroid function test abnormal, Nasal congestion, Illness, Myalgia, Feeling hot, Oropharyngeal pain, Body temperature increased, Brain fog, Urticaria, Live birth, |
||||
ACYCLOVIR, ALEMTUZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CANNABIDIOL, CIMETIDINE, DIMENHYDRINATE, MELATONIN, METHYLPREDNISOLONE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, |
||||
| 497 | 25087111 |
US |
42 | 2 |
Tumour pain, Crying, Pruritus, Cough, Oropharyngeal pain, Fatigue, Productive cough, Illness, Somnolence, Diarrhoea, Hypophagia, Retching, Nausea, Headache, Feeling abnormal, Pain, Influenza like illness, Insomnia, Restless legs syndrome, Vomiting, Pyrexia, Chills, Migraine, Abdominal pain, Product dose omission issue, |
||||
ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, NIROGACESTAT, NIROGACESTAT, PROCHLORPERAZINE, PROCHLORPERAZINE, |
||||
| 498 | 25087395 |
US |
2 | |
Illness, Throat irritation, |
||||
CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, |
||||
| 499 | 25087419 |
US |
36 | 2 |
Product dose omission issue, Illness, Incorrect dose administered, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 500 | 25087548 |
US |
27 | 2 |
Nausea, Vertigo, Drug ineffective, Illness, Product quality issue, |
||||
TRAZODONE HYDROCHLORIDE, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28